Skip to content

Establishment of chemobrain estimation by measuring exosome.

Establishment of chemobrain estimation by measuring exosome. - Clinical trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047302
Enrollment
100
Registered
2022-05-01
Start date
2022-04-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

blood test, 10 times. brain function test, 4 times.

Sponsors

Kawasaki Medical School
Lead Sponsor
NanoSomiX co.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: First chemotherapy after diagnosis of cancer,

Exclusion criteria

Exclusion criteria: Those who are suffering from serious recognition disorder or psychiatric disease.

Design outcomes

Primary

MeasureTime frame
Chemobrain status will be evaluated by cognitive function tests and analyzed for correlation with blood exosome levels and changes.

Countries

Japan

Contacts

Public ContactTakuya Murata

Kawasaki Medical School Obstetrics and Gynecology

t.muratactac@gmail.com0862552111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026